EP 1799240 A4 20090722 - TREATMENT OF BONE DISORDERS WITH SKELETAL ANABOLIC DRUGS
Title (en)
TREATMENT OF BONE DISORDERS WITH SKELETAL ANABOLIC DRUGS
Title (de)
BEHANDLUNG VON KNOCHENERKRANKUNGEN MIT SKELETTALEN ANABOLIKA
Title (fr)
TRAITEMENT DES AFFECTIONS OSSEUSES A L'AIDE DE MEDICAMENTS ANABOLISANTS DU SQUELETTE
Publication
Application
Priority
- US 2005032706 W 20050914
- US 61028304 P 20040916
Abstract (en)
[origin: WO2006033912A2] Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
IPC 8 full level
A61K 38/00 (2006.01)
CPC (source: EP)
A61K 38/29 (2013.01); A61P 3/14 (2017.12); A61P 5/18 (2017.12); A61P 13/12 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12)
Citation (search report)
- [X] HORWITZ MARA J ET AL: "Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM FEB 2003, vol. 88, no. 2, February 2003 (2003-02-01), pages 569 - 575, XP002530462, ISSN: 0021-972X
- See references of WO 2006033912A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006033912 A2 20060330; WO 2006033912 A3 20060629; WO 2006033912 B1 20060908; AU 2005287139 A1 20060330; CA 2580281 A1 20060330; EP 1799240 A2 20070627; EP 1799240 A4 20090722; JP 2008513459 A 20080501; MX 2007003185 A 20071016
DOCDB simple family (application)
US 2005032706 W 20050914; AU 2005287139 A 20050914; CA 2580281 A 20050914; EP 05797693 A 20050914; JP 2007532415 A 20050914; MX 2007003185 A 20050914